Updated
September 30th, 2016

Ebola Vaccine Appeared Effective

VSV-EBOV Ebola vaccine, from GlaxoSmithKline, appeared effective in fight against Ebola

Ebola virus

The VSV-EBOV vaccine is a bright spot in the fight against Ebola. Early tests of the experimental Ebola vaccine found it to be highly effective, according to the World Health Organization (WHO).

Studies on this vaccine, which only requires one dose, began in March of 2015 in Guinea, where Ebola ravaged the country in one of the largest Ebola outbreaks in history.

Based on these trials, WHO officials said they planned to deploy the vaccine immediately to at-risk groups, reported CNN.

Over 4,000 at-risk patients voluntarily participated in the WHO trial, as well as over 1,200 health workers.

Sponsored Links:

The results suggested that the vaccine was 100 percent effective.

The trial results were published in The Lancet.

Funding came from WHO, the Wellcome Trust, Médecins Sans Frontières, the Norwegian Ministry of Foreign Affairs and the Canadian government.

Researchers disclosed financial ties to GlaxoSmithKline, which developed the vaccine, and WHO.